A review of genome mutation and Alzheimer's disease.

Alzheimer's disease (AD) is a complex progressive neurodegenerative disorder of the brain and is the commonest form of dementia. The prevalence of this disease is predicted to increase 3-fold over the next 30 years and to date no reliable and conclusive diagnostic test exists that will identify individuals presymptomatically of susceptibility risk. This review examines the molecular, genetic, dietary and environmental evidence underlying the known pathology of AD and proposes a biologically plausible chromosome instability model to explain some of the features of the disease. Genome damage biomarkers such as aneuploidy of chromosome 17 and 21, oxidative damage to DNA and telomere shortening together with abnormal expression of APP, beta amyloid and tau proteins are discussed in terms of their potential value as risk biomarkers. These biomarkers could then be used in diagnosis and the evaluation of potentially effective preventative measures.

[1]  M. Hande,et al.  Accelerated telomere shortening in the human inactive X chromosome. , 1999, American journal of human genetics.

[2]  G. Beecher,et al.  Lipophilic and hydrophilic antioxidant capacities of common foods in the United States. , 2004, Journal of agricultural and food chemistry.

[3]  Xudong Huang,et al.  Dramatic Aggregation of Alzheimer Aβ by Cu(II) Is Induced by Conditions Representing Physiological Acidosis* , 1998, The Journal of Biological Chemistry.

[4]  R. DePinho,et al.  Connecting chromosomes, crisis, and cancer. , 2002, Science.

[5]  S. Barnes,et al.  Proteomics analysis of rat brain protein modulations by grape seed extract. , 2004, Journal of agricultural and food chemistry.

[6]  V. L. Wilson,et al.  Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. , 1999, The American journal of clinical nutrition.

[7]  L. Migliore,et al.  Preferential occurrence of chromosome 21 malsegregation in peripheral blood lymphocytes of Alzheimer disease patients , 1999, Cytogenetic and Genome Research.

[8]  A. Nunomura,et al.  Oxidative Damage Is the Earliest Event in Alzheimer Disease , 2001, Journal of neuropathology and experimental neurology.

[9]  Mark A. Smith,et al.  Carbonyl‐Related Posttranslational Modification of Neurofilament Protein in the Neurofibrillary Pathology of Alzheimer's Disease , 1995, Journal of neurochemistry.

[10]  J. Weber,et al.  Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. , 1992, Science.

[11]  K. Abe,et al.  The possible role of hydrogen sulfide as an endogenous neuromodulator , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[12]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[13]  S. Melquist,et al.  Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 , 2006, Nature.

[14]  Steven M. Horvath,et al.  Alpha-2 macroglobulin is genetically associated with Alzheimer disease , 1998, Nature Genetics.

[15]  L. Migliore,et al.  Spontaneous and induced aneuploidy in peripheral blood lymphocytes of patients with Alzheimer’s disease , 1997, Human Genetics.

[16]  A. McCaddon,et al.  Alzheimer’s disease and total plasma aminothiols , 2003, Biological Psychiatry.

[17]  A. Jauch,et al.  Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas , 2001, Oncogene.

[18]  T. Ohm,et al.  Scientific progress and a Hardy paradigm—the ‘amyloid cascade hypothesis’ revisited , 2004, Neurobiology of Aging.

[19]  M. Fenech.  The role of folic acid and Vitamin B12 in genomic stability of human cells. , 2001, Mutation research.

[20]  R. Cawthon,et al.  Association between telomere length in blood and mortality in people aged 60 years or older , 2003, The Lancet.

[21]  M. Fenech,et al.  Folate deficiency induces aneuploidy in human lymphocytes in vitro-evidence using cytokinesis-blocked cells and probes specific for chromosomes 17 and 21. , 2004, Mutation research.

[22]  H. Blom,et al.  A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease risk , 2001, Journal of Molecular Medicine.

[23]  P. Bertolucci,et al.  Differential chromosome sensitivity to 5-azacytidine in Alzheimer's disease. , 1998, Gerontology.

[24]  J. Auer,et al.  Homocysteine and dementia. , 2002, The New England journal of medicine.

[25]  A. Minihane,et al.  Dietary vitamin E modulates differential gene expression in the rat hippocampus: Potential implications for its neuroprotective properties , 2005, Nutritional neuroscience.

[26]  D. Mann,et al.  The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome , 1989, Journal of the Neurological Sciences.

[27]  A Hofman,et al.  Homocysteine and brain atrophy on MRI of non-demented elderly. , 2003, Brain : a journal of neurology.

[28]  C. Dingwall,et al.  In search of an enzyme: the β-secretase of Alzheimer's disease is an aspartic proteinase , 2000, Trends in Neurosciences.

[29]  James Lyons-Weiler,et al.  Homocysteine, folate deprivation and Alzheimer neuropathology. , 2002, Journal of Alzheimer's disease : JAD.

[30]  P. S. St George-Hyslop,et al.  Biology of presenilins as causative molecules for Alzheimer disease , 1999, Clinical genetics.

[31]  F. D’Anselmi,et al.  S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production , 2005, Molecular and Cellular Neuroscience.

[32]  D. Pollen,et al.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.

[33]  Jonathan D. Smith,et al.  Apolipoprotein E allele–specific antioxidant activity and effects on cytotoxicity by oxidative insults and β–amyloid peptides , 1996, Nature Genetics.

[34]  David Morgan,et al.  Green Tea Epigallocatechin-3-Gallate (EGCG) Modulates Amyloid Precursor Protein Cleavage and Reduces Cerebral Amyloidosis in Alzheimer Transgenic Mice , 2005, The Journal of Neuroscience.

[35]  M. Mesulam,et al.  The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy , 2003, Acta Neuropathologica.

[36]  D. Perl,et al.  Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. , 1980, Science.

[37]  J. D. Robertson,et al.  Copper, iron and zinc in Alzheimer's disease senile plaques , 1998, Journal of the Neurological Sciences.

[38]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[39]  K. Santacruz,et al.  Early diagnosis of dementia. , 2001, American family physician.

[40]  S. Ph.  Piecing Together Alzheimer's , 2000 .

[41]  J. Hardy,et al.  Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP , 2001, Science.

[42]  Saumya Das,et al.  Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1 , 1995, Neuron.

[43]  A. Risch,et al.  Short Telomeres in Patients with Vascular Dementia: An Indicator of Low Antioxidative Capacity and a Possible Risk Factor? , 2000, Laboratory Investigation.

[44]  P. Yates,et al.  THE TOPOGRAPHY OF PLAQUES AND TANGLES IN DOWN'S SYNDROME PATIENTS OF DIFFERENT AGES , 1986, Neuropathology and applied neurobiology.

[45]  R Clarke,et al.  Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. , 1998, Archives of neurology.

[46]  A. Paetau,et al.  A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1 , 1998, Nature Medicine.

[47]  Sang Won Suh,et al.  Histochemically-reactive zinc in amyloid plaques, angiopathy, and degenerating neurons of Alzheimer's diseased brains , 2000, Brain Research.

[48]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[49]  R. Matthews,et al.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.

[50]  D. Selkoe,et al.  Alzheimer disease: mechanistic understanding predicts novel therapies. , 2004 .

[51]  M. Catani,et al.  Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. , 2002, Archives of neurology.

[52]  D. Blacker,et al.  Family-based association between Alzheimer's disease and variants in UBQLN1. , 2005, The New England journal of medicine.

[53]  Nobuhisa Iwata,et al.  19F and 1H MRI detection of amyloid β plaques in vivo , 2005, Nature Neuroscience.

[54]  T. Asada,et al.  Association between Tau polymorphism and male early-onset Alzheimer's disease , 2004, Neuroreport.

[55]  M. Fortini,et al.  Proteolysis in Alzheimer's disease , 2000, EMBO reports.

[56]  J. H. Schwartz,et al.  Long-Term Memory Requires PolyADP-ribosylation , 2004, Science.

[57]  R. Terry.  The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis. , 1996, Journal of neuropathology and experimental neurology.

[58]  N. Leach,et al.  Human chromosomes with shorter telomeres and large heterochromatin regions have a higher frequency of acquired somatic cell aneuploidy , 2004, Mechanisms of Ageing and Development.

[59]  C. Cotman,et al.  Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[60]  Khadija Iqbal,et al.  Identification and localization of a tau peptide to paired helical filaments of Alzheimer disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[61]  J. Hardy,et al.  The genetic causes of neurodegenerative diseases. , 2001, Journal of Alzheimer's disease : JAD.

[62]  M. Beal.  Oxidative damage as an early marker of Alzheimer's disease and mild cognitive impairment , 2005, Neurobiology of Aging.

[63]  G. Schellenberg,et al.  Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease , 1996, Nature Medicine.

[64]  Jun Wang,et al.  Neuronal SIRT1 Activation as a Novel Mechanism Underlying the Prevention of Alzheimer Disease Amyloid Neuropathology by Calorie Restriction* , 2006, Journal of Biological Chemistry.

[65]  T. Stadtman,et al.  Vitamin B12 , 1971, Science.

[66]  John Hardy,et al.  Amyloid, the presenilins and Alzheimer's disease , 1997, Trends in Neurosciences.

[67]  Sudha Seshadri,et al.  Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease , 2002 .

[68]  K. Ono,et al.  Preformed β-amyloid fibrils are destabilized by coenzyme Q10 in vitro , 2005 .

[69]  George Perry,et al.  Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation. , 2003, The American journal of pathology.

[70]  Patrick R. Hof,et al.  Tau protein isoforms, phosphorylation and role in neurodegenerative disorders 1 1 These authors contributed equally to this work. , 2000, Brain Research Reviews.

[71]  H. Wiśniewski,et al.  Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome , 1985, Annals of neurology.

[72]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[73]  L. Bailey,et al.  Folate in Health and Disease , 2009 .

[74]  M. S. Morris.  Homocysteine and Alzheimer's disease , 2003, The Lancet Neurology.

[75]  P. Jones,et al.  Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. , 1997, Carcinogenesis.

[76]  S. Chandra,et al.  A second cytotoxic proteolytic peptide derived from amyloid β-protein precursor , 2000, Nature Medicine.

[77]  M. Mattson,et al.  Folic Acid Deficiency and Homocysteine Impair DNA Repair in Hippocampal Neurons and Sensitize Them to Amyloid Toxicity in Experimental Models of Alzheimer's Disease , 2002, The Journal of Neuroscience.

[78]  H. Braak,et al.  Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories , 1997, Neurobiology of Aging.

[79]  G. Forloni.  β-amyloid neurotoxicity , 1993 .

[80]  A. Paetau,et al.  Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS‐1 mutations that lead to exceptionally high amyloid‐β concentrations , 2000, Annals of neurology.

[81]  B. Winblad,et al.  Vitamin B12 and folate in relation to the development of Alzheimer’s disease , 2001, Neurology.

[82]  G. Perry,et al.  Identification of Ubiquilin, a Novel Presenilin Interactor That Increases Presenilin Protein Accumulation , 2000, The Journal of cell biology.

[83]  John M. Lee,et al.  Hypomethylation of the amyloid precursor protein gene in the brain of an alzheimer’s disease patient , 2007, Journal of Molecular Neuroscience.

[84]  Khadija Iqbal,et al.  Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles. , 1998, Journal of neural transmission. Supplementum.

[85]  L. Baum,et al.  Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models. , 2004, Journal of Alzheimer's disease : JAD.

[86]  M. Mattson,et al.  Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders , 2003, Trends in Neurosciences.

[87]  Y. Surh,et al.  Protective Effects of Oligomers of Grape Seed Polyphenols Against β‐Amyloid‐Induced Oxidative Cell Death , 2004, Annals of the New York Academy of Sciences.

[88]  J. Bayley.  Elegy for Iris , 1999 .

[89]  J. Poirier.  Apolipoprotein E in animal models of CNS injury and in alzheimer's disease , 1994, Trends in Neurosciences.

[90]  John Hardy,et al.  Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau , 1998, Nature Neuroscience.

[91]  R. Chang,et al.  Modulation of calcium/calmodulin kinase‐II provides partial neuroprotection against beta‐amyloid peptide toxicity , 2004, The European journal of neuroscience.

[92]  S. Mandel,et al.  Green tea catechins as brain-permeable, natural iron chelators-antioxidants for the treatment of neurodegenerative disorders. , 2006, Molecular nutrition & food research.

[93]  David Shore.  Telomeres--Unsticky Ends , 1998, Science.

[94]  L. Migliore,et al.  Cytogenetic alterations in lymphocytes of Alzheimer's disease and Parkinson's disease patients , 2002, Neurological Sciences.

[95]  J. D. McGaugh,et al.  Intraneuronal Aβ Causes the Onset of Early Alzheimer’s Disease-Related Cognitive Deficits in Transgenic Mice , 2005, Neuron.

[96]  T. Wisniewski,et al.  Biology of Aβ Amyloid in Alzheimer's Disease , 1997, Neurobiology of Disease.

[97]  Xudong Huang,et al.  The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. , 1999, Biochemistry.

[98]  C. Cotman,et al.  Alzheimer‐associated presenilin‐2 confers increased sensitivity to poptosis in PC12 cells , 1996, FEBS letters.

[99]  S. Paul,et al.  Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition , 1997, Nature Genetics.

[100]  Kevin M Bradley,et al.  Minimal hippocampal width relates to plasma homocysteine in community-dwelling older people. , 2002, Age and ageing.

[101]  M. Bobinski,et al.  Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories , 1997, Neurobiology of Aging.

[102]  R. A. Crowther,et al.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease , 1989, Neuron.

[103]  J. Price,et al.  Cerebral amyloid deposition and diffuse plaques in ``normal'' aging , 1996, Neurology.

[104]  C. Cotman,et al.  Neuronal Apoptosis Induced by β-Amyloid Is Mediated by Caspase-8 , 1999, Neurobiology of Disease.

[105]  Fusheng Yang,et al.  Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo* , 2005, Journal of Biological Chemistry.

[106]  E. Génin,et al.  ABCA2 is a strong genetic risk factor for early-onset Alzheimer's disease , 2005, Neurobiology of Disease.

[107]  D. Mann,et al.  Presence of soluble amyloid β–peptide precedes amyloid plaque formation in Down's syndrome , 1996, Nature Medicine.

[108]  Deborah Gustafson,et al.  Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. , 2004, Archives of neurology.

[109]  J. Hardy,et al.  Amyloid deposition as the central event in the aetiology of Alzheimer's disease. , 1991, Trends in pharmacological sciences.

[110]  J. Blangero,et al.  Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. , 2000, Science.

[111]  D. Selkoe.  Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.

[112]  H. Potter,et al.  Review and hypothesis: Alzheimer disease and Down syndrome--chromosome 21 nondisjunction may underlie both disorders. , 1991, American journal of human genetics.

[113]  Miia Kivipelto,et al.  Utilization of cognitive support in episodic free recall as a function of apolipoprotein E and vitamin B12 or folate among adults aged 75 years and older. , 2004, Neuropsychology.

[114]  R. Plomin,et al.  Polymorphisms of genes controlling homocysteine/folate metabolism and cognitive function , 2000, Neuroreport.

[115]  J. Mate,et al.  Methionine synthase polymorphism is a risk factor for Alzheimer disease , 2003, Neuroreport.

[116]  E. Masliah,et al.  Association of monoamine oxidase A gene polymorphism with Alzheimer's disease and Lewy body variant , 2002, Neuroscience Letters.

[117]  D. Bennett,et al.  Dietary niacin and the risk of incident Alzheimer’s disease and of cognitive decline , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[118]  R. Nagatomi,et al.  Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project 1. , 2006, The American journal of clinical nutrition.

[119]  D. Selkoe,et al.  Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments , 1992, Nature.

[120]  R. Ward,et al.  Short telomeres on human chromosome 17p. , 1998 .

[121]  Jae-Young Koh,et al.  Histochemically Reactive Zinc in Plaques of the Swedish Mutant β-Amyloid Precursor Protein Transgenic Mice , 1999, The Journal of Neuroscience.

[122]  M. Bullido,et al.  A polymorphism in the tau gene associated with risk for Alzheimer's disease , 2000, Neuroscience Letters.

[123]  J. Yesavage,et al.  α2 Macroglobulin and the risk of Alzheimer’s disease , 2000, Neurology.

[124]  G. Perry,et al.  How important is oxidative damage? Lessons from Alzheimer's disease. , 2000, Free radical biology & medicine.

[125]  C. Masters,et al.  Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. , 1999, The Journal of biological chemistry.

[126]  M. Spitz,et al.  Telomere dysfunction: a potential cancer predisposition factor. , 2003, Journal of the National Cancer Institute.

[127]  J. Cummings,et al.  Telomere shortening in T cells correlates with Alzheimer’s disease status , 2003, Neurobiology of Aging.

[128]  M. Mattson.  Pathways towards and away from Alzheimer's disease , 2004, Nature.

[129]  Trond Peder Flaten,et al.  Aluminium as a risk factor in Alzheimer’s disease, with emphasis on drinking water , 2001, Brain Research Bulletin.

[130]  J. Grafman,et al.  Frontotemporal dementia with novel tau pathology and a Glu342Val tau mutation , 2000, Annals of neurology.

[131]  W. Markesbery,et al.  Increased DNA Oxidation and Decreased Levels of Repair Products in Alzheimer's Disease Ventricular CSF , 1999, Journal of neurochemistry.

[132]  Yutaka Kirino,et al.  Cleavage of Alzheimer’s Amyloid Precursor Protein (APP) by Secretases Occurs after O-Glycosylation of APP in the Protein Secretory Pathway , 1998, The Journal of Biological Chemistry.

[133]  Junying Yuan,et al.  Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β , 2000, Nature.

[134]  W. Markesbery,et al.  Increased Nuclear DNA Oxidation in the Brain in Alzheimer's Disease , 1998, Journal of neurochemistry.

[135]  E. Okello,et al.  In vitro anti‐β‐secretase and dual anti‐cholinesterase activities of Camellia sinensis L. (tea) relevant to treatment of dementia , 2004, Phytotherapy research : PTR.

[136]  Allen D. Roses,et al.  A model for susceptibility polymorphisms for complex diseases: apolipoprotein E and Alzheimer disease , 1997, Neurogenetics.

[137]  Xudong Huang,et al.  Evidence that the β-Amyloid Plaques of Alzheimer's Disease Represent the Redox-silencing and Entombment of Aβ by Zinc* , 2000, The Journal of Biological Chemistry.

[138]  T. Bayer,et al.  A modified β‐amyloid hypothesis: intraneuronal accumulation of the β‐amyloid peptide – the first step of a fatal cascade , 2004, Journal of neurochemistry.

[139]  T. Ohm,et al.  Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology , 2004, Neurobiology of Aging.

[140]  B. Mcdonald,et al.  Absence of aluminium in neuritic plaque cores in Alzheimer's disease , 1992, Nature.

[141]  S. Younkin,et al.  An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. , 1994, Science.

[142]  C. DeCarli,et al.  A pilot study of vitamins to lower plasma homocysteine levels in Alzheimer disease. , 2003, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[143]  G. Perry,et al.  Tau phosphorylation and assembly. , 2004, Acta neurobiologiae experimentalis.

[144]  A. Goate,et al.  Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease , 1996, The Lancet.

[145]  C. Duijn,et al.  Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer's disease and variable expression. , 2000, Human molecular genetics.

[146]  A. Raina,et al.  Homocysteine and Alzheimer's disease: a modifiable risk? , 2004, Free radical biology & medicine.

[147]  J. Murnane,et al.  DNA amplification by breakage/fusion/bridge cycles initiated by spontaneous telomere loss in a human cancer cell line. , 2002, Neoplasia.

[148]  A. Bush.  Metal complexing agents as therapies for Alzheimer’s disease , 2002, Neurobiology of Aging.

[149]  C. Wagner.  BIOCHEMICAL ROLE OF FOLATE IN CELLULAR METABOLISM* , 2001 .

[150]  O. Combarros,et al.  The myeloperoxidase gene in Alzheimer's disease: a case-control study and meta-analysis , 2002, Neuroscience Letters.

[151]  K. Nakashima,et al.  A haplotype of the methylenetetrahydrofolate reductase gene is protective against late-onset Alzheimer’s disease , 2004, Neurobiology of Aging.

[152]  Patrizia Mecocci,et al.  Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease , 1994, Annals of neurology.

[153]  J. Price,et al.  So what if tangles precede plaques? , 2004, Neurobiology of Aging.

[154]  D. Teplow,et al.  A Furin-like Convertase Mediates Propeptide Cleavage of BACE, the Alzheimer's β-Secretase* , 2000, The Journal of Biological Chemistry.

[155]  D. Perl,et al.  Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: A laser microprobe (LAMMA) study , 1992, Annals of neurology.

[156]  B. Shukitt-Hale,et al.  Blueberry Supplementation Enhances Signaling and Prevents Behavioral Deficits in an Alzheimer Disease Model , 2003, Nutritional neuroscience.

[157]  S. Sevush,et al.  Association between Alzheimer's Disease and a Functional Polymorphism in the Myeloperoxidase Gene , 2001, Experimental Neurology.

[158]  Andrea Fuso,et al.  Presenilin 1 gene silencing by S‐adenosylmethionine: a treatment for Alzheimer disease? , 2003, FEBS letters.

[159]  A. McCaddon,et al.  Total serum homocysteine in senile dementia of Alzheimer type , 1998, International journal of geriatric psychiatry.

[160]  A. Bush,et al.  Metals and neuroscience. , 2000, Current opinion in chemical biology.

[161]  A. Ritchie,et al.  A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer’s disease , 2005, Neurobiology of Aging.

[162]  M. Fujii,et al.  Demethylation of classical satellite 2 and 3 DNA with chromosomal instability in senescent human fibroblasts , 2002, Experimental Gerontology.

[163]  J. Cummings,et al.  A potential role of the curry spice curcumin in Alzheimer's disease. , 2005, Current Alzheimer research.

[164]  T. Asada,et al.  Brain hydrogen sulfide is severely decreased in Alzheimer's disease. , 2002, Biochemical and biophysical research communications.

[165]  Xiongwei Zhu,et al.  Comparative biology and pathology of oxidative stress in Alzheimer and other neurodegenerative diseases: beyond damage and response. , 2002, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.

[166]  G. Schellenberg,et al.  Genetic dissection of Alzheimer disease, a heterogeneous disorder. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[167]  F. Coppedè,et al.  Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients , 2005, Neurobiology of Aging.

[168]  Jinhe Li,et al.  Alzheimer Presenilins in the Nuclear Membrane, Interphase Kinetochores, and Centrosomes Suggest a Role in Chromosome Segregation , 1997, Cell.

[169]  M. Citron,et al.  Aβ-Generating Enzymes Recent Advances in β- and γ-Secretase Research , 2000, Neuron.

[170]  Á. M. Patterson,et al.  Serum selenium is associated with plasma homocysteine concentrations in elderly humans. , 2004, The Journal of nutrition.

[171]  C. Masters,et al.  Mechanisms of peripheral microvascular dysfunction in transgenic mice overexpressing the Alzheimer's disease amyloid Abeta protein. , 2002, Journal of Alzheimer's disease : JAD.

[172]  Y. Christen,et al.  Oxidative stress and Alzheimer disease. , 2000, The American journal of clinical nutrition.

[173]  Tangles and plaques in healthy aging and Alzheimer's disease: independence or interaction? , 1994 .

[174]  M. Fenech,et al.  Micronuclei, nucleoplasmic bridges and nuclear buds induced in folic acid deficient human lymphocytes-evidence for breakage-fusion-bridge cycles in the cytokinesis-block micronucleus assay. , 2002, Mutation research.

[175]  D. Hewitt,et al.  Aluminium, Alzheimer's disease, and drinking water , 1991, The Lancet.

[176]  Barbara Shukitt-Hale,et al.  Reversals of Age-Related Declines in Neuronal Signal Transduction, Cognitive, and Motor Behavioral Deficits with Blueberry, Spinach, or Strawberry Dietary Supplementation , 1999, The Journal of Neuroscience.

[177]  R. Kolodner,et al.  Recombination and the Tel1 and Mec1 checkpoints differentially effect genome rearrangements driven by telomere dysfunction in yeast , 2004, Nature Genetics.

[178]  B. Hyman,et al.  Aβ Deposition Is Associated with Neuropil Changes, but not with Overt Neuronal Loss in the Human Amyloid Precursor Protein V717F (PDAPP) Transgenic Mouse , 1997, The Journal of Neuroscience.

[179]  Konrad Maurer,et al.  Auguste D and Alzheimer's disease , 1997, The Lancet.

[180]  B. Mcclintock.  SPONTANEOUS ALTERATIONS IN CHROMOSOME SIZE AND FORM IN ZEA MAYS , 1941 .

[181]  H. Potter,et al.  Chromosome Missegregation and Trisomy 21 Mosaicism in Alzheimer's Disease , 1999, Neurobiology of Disease.

[182]  E. Koo.  The β‐Amyloid Precursor Protein (APP) and Alzheimer's Disease: Does the Tail Wag the Dog? , 2002, Traffic.

[183]  S. Kish,et al.  Brain S‐Adenosylmethionine Levels Are Severely Decreased in Alzheimer's Disease , 1996, Journal of neurochemistry.

[184]  H. Braak,et al.  Alzheimer’s disease: intraneuronal alterations precede insoluble amyloid-β formation , 2004, Neurobiology of Aging.

[185]  John Shi,et al.  Polyphenolics in grape seeds-biochemistry and functionality. , 2003, Journal of medicinal food.

[186]  J. Buxbaum,et al.  Aβ localization in abnormal endosomes: association with earliest Aβ elevations in AD and Down syndrome , 2004, Neurobiology of Aging.

[187]  C. Mathers,et al.  Global prevalence of dementia: a Delphi consensus study , 2005, The Lancet.

[188]  M G McInnis,et al.  Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. , 2000, Science.

[189]  B. Winblad,et al.  The Magnitude of Dementia Occurrence in the World , 2003, Alzheimer disease and associated disorders.

[190]  B. Giusti,et al.  The C677T methylenetetrahydrofolate reductase mutation is not associated with Alzheimer's disease , 2001, Neuroscience Letters.

[191]  P. Mecocci,et al.  Oxidative damage to DNA in lymphocytes from AD patients , 1998, Neurology.

[192]  M. Mattson,et al.  Evidence for Synaptic Apoptosis , 1998, Experimental Neurology.

[193]  R. Marcos,et al.  Multicolour FISH detection of radioactive iodine-induced 17cen-p53 chromosomal breakage in buccal cells from therapeutically exposed patients. , 2000, Carcinogenesis.

[194]  R. Martins,et al.  Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. , 1985, The EMBO journal.

[195]  Nathalie Rufer,et al.  Telomere Fluorescence Measurements in Granulocytes and T Lymphocyte Subsets Point to a High Turnover of Hematopoietic Stem Cells and Memory T Cells in Early Childhood , 1999, The Journal of experimental medicine.